Your browser doesn't support javascript.
loading
Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review.
Beber, A; Dellai, F; Abdel Jaber, M; Peterlana, D; Brunori, G; Maino, A.
Afiliación
  • Beber A; Respiratory Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
  • Dellai F; Respiratory Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
  • Abdel Jaber M; Department of Medicine, Rheumatology Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
  • Peterlana D; Department of Medicine, Internal Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
  • Brunori G; Respiratory Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
  • Maino A; Department of Medicine, Internal Medicine Unit, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
Scand J Rheumatol ; 51(1): 67-69, 2022 01.
Article en En | MEDLINE | ID: mdl-34169783
Objective: Systemic capillary leak syndrome (SCLS) is a severe condition characterized by the coexistence of hypovolaemic shock, haemococentration, and hypoalbuminaemia, without albuminuria, that may progress to multiorgan failure and an unfavourable outcome. Its development is often triggered by viral infections, such as influenza A virus, but it is unclear whether it is also triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We aimed to investigated the association between SARS-CoV-2 and SCLS.Method: We present the case of a 55-year-old-woman affected by SARS-CoV-2 infection who developed SCLS. Moreover, we performed a systematic review of the literature to identify any common features with other cases and to describe clinical characteristics and outcomes.Results: We found three other cases of SCLS occurring during SARS-CoV-2 infection in 2020. Taking all cases together, the mean age was 50 years (range 38-63), with a 1:1 gender ratio. Respiratory manifestations were the most common symptom, and all patients required admission to the intensive care unit. The mortality rate was 50%.Conclusions: SARS-CoV-2 infection may trigger SCLS disease, either by an overproduction of proinflammatory cytokines or by direct viral infection of the endothelium. Since SCLS may have a poor prognosis, in every SARS-CoV-2-infected patient presenting the suggestive triad of hypovolaemic shock, haemoconcentration, and hypoproteinaemia, an SCLS diagnosis should be considered and early treatment initiated.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Fuga Capilar / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Fuga Capilar / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido